心力衰竭的免疫学与保存的喷射分数
Charles Duncan Smart1, Meena S Madhur1,2,3,4
1Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, U.S.A.
Clinical science (London, England : 1979)
|August 22, 2023
概括
炎症可能导致心力衰竭与保留喷射分数 (HFpEF),这是一个常见的和严重的条件缺乏治疗. 了解免疫细胞在HFpEF中的作用可能会揭示新的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭越来越普遍和病态,治疗选择有限.
- 包括肥胖,高血压和衰老在内的HFpEF风险因素与慢性炎症有关.
- 炎症在HFpEF病原发生中的确切作用尚不清楚.
研究的目的:
- 在动物模型和人类中审查涉及炎症在HFpEF病原体的证据.
- 确定有关将炎症与HFpEF联系起来的机制的知识差距.
- 探索针对新型HFpEF疗法的炎症途径的潜力.
主要方法:
- 来自HFpEF的动物模型的临床前证据的审查.
- 对研究HFpEF炎症的人类研究的分析.
- 综合目前对免疫细胞参与HFpEF的理解.
主要成果:
- 临床前数据表明,免疫细胞和细胞因子有助于HFpEF的特征,如纤维化和氧化应激.
- 慢性炎症疾病与HFpEF具有共同的风险因素.
- 特定的免疫细胞子集和炎症途径与HFpEF的发展有关.
结论:
- 炎症是HFpEF病变发生的可能媒介.
- 对HFpEF中免疫细胞激活机制的进一步研究至关重要.
- 针对炎症为HFpEF提供了一个潜在的治疗途径.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Heart Failure I: Introduction
16
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
16
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure III: Clinical Manifestations
23
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
23
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16


